Good afternoon :)
Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd

ARVEE Share Price

NSE
154.000.65% (-1.00)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹169 cr, stock is ranked 2,625

Stock is 5.51x as volatile as Nifty

ARVEE Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹169 cr, stock is ranked 2,625

Stock is 5.51x as volatile as Nifty

ARVEE Performance & Key Metrics

ARVEE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
81.595.83
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
29.393.361.53%

ARVEE Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ARVEE Company Profile

Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates

ARVEE Similar Stocks (Peers)

Compare with peers Compare with peers 

ARVEE Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
66.72
66.72
1Y Return
3.67%
3.67%
Buy Reco %
66.67
66.67
PE Ratio
111.33
111.33
1Y Return
63.82%
63.82%
Buy Reco %
75.00
75.00
PE Ratio
47.45
47.45
1Y Return
13.49%
13.49%
Buy Reco %
85.00
85.00
PE Ratio
36.14
36.14
1Y Return
8.11%
8.11%
Buy Reco %
72.73
72.73
PE Ratio
148.52
148.52
1Y Return
71.68%
71.68%
Buy Reco %
42.86
42.86
Compare with Peers

ARVEE Forecast

ARVEE Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ARVEE

ARVEE

Income

Balance Sheet

Cash Flow

ARVEE Income Statement

ARVEE Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue9.007.896.3510.7112.689.106.667.653.689.92
Operating & Other expensessubtract8.227.175.359.0711.028.566.237.143.328.16
Depreciation/Amortizationsubtract0.420.350.370.310.300.280.270.290.300.30
Interest & Other Itemssubtract0.080.050.050.080.050.050.070.040.040.07
Taxes & Other Itemssubtract0.070.080.470.320.330.050.020.010.00-0.43
EPS0.190.220.110.850.890.140.060.150.011.66

ARVEE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

ARVEE Stock Peers

ARVEE Past Performance & Peer Comparison

ARVEE Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Arvee Laboratories (India) Ltd79.305.83
Gujarat Fluorochemicals Ltd66.724.990.09%
Navin Fluorine International Ltd111.3312.230.11%
Aarti Industries Ltd47.452.800.23%

ARVEE Stock Price Comparison

Compare ARVEE with any stock or ETF
Compare ARVEE with any stock or ETF
ARVEE
Loading...

ARVEE Holdings

ARVEE Shareholdings

ARVEE Promoter Holdings Trend

ARVEE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ARVEE Institutional Holdings Trend

ARVEE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ARVEE Shareholding Pattern

ARVEE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.50%0.00%0.00%0.00%26.50%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

ARVEE Shareholding History

ARVEE Shareholding History

SepDec '24MarJunSepDec '250.00%0.00%0.00%0.00%0.00%0.00%

ARVEE Insider Trades & Bulk Stock Deals

ARVEE Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ARVEE stock

smallcases containing ARVEE stock

Looks like this stock is not in any smallcase yet.

ARVEE Events

ARVEE Events

ARVEE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ARVEE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

ARVEE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ARVEE has not given any dividends in last 5 years

ARVEE Dividends

ARVEE Dividends

Hmm, looks like data is unavailable here. Please come back after some time

ARVEE Stock News & Opinions

ARVEE Stock News & Opinions

Earnings
Arvee Laboratories (India) standalone net profit rises 1120.00% in the December 2025 quarter

Net profit of Arvee Laboratories (India) rose 1120.00% to Rs 1.83 crore in the quarter ended December 2025 as against Rs 0.15 crore during the previous quarter ended December 2024. Sales rose 9.76% to Rs 9.78 crore in the quarter ended December 2025 as against Rs 8.91 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales9.788.91 10 OPM %16.673.82 - PBDT1.700.48 254 PBT1.400.20 600 NP1.830.15 1120 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Arvee Laboratories (India) to announce Quarterly Result

Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit declines 98.98% in the September 2025 quarter

Net profit of Arvee Laboratories (India) declined 98.98% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.98 crore during the previous quarter ended September 2024. Sales declined 72.47% to Rs 3.45 crore in the quarter ended September 2025 as against Rs 12.53 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3.4512.53 -72 OPM %3.4811.97 - PBDT0.311.61 -81 PBT0.011.31 -99 NP0.010.98 -99 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to announce Quarterly Result

Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to convene AGM

Arvee Laboratories (India) announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit declines 81.91% in the June 2025 quarter

Net profit of Arvee Laboratories (India) declined 81.91% to Rs 0.17 crore in the quarter ended June 2025 as against Rs 0.94 crore during the previous quarter ended June 2024. Sales declined 29.43% to Rs 7.48 crore in the quarter ended June 2025 as against Rs 10.60 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales7.4810.60 -29 OPM %4.5514.53 - PBDT0.471.57 -70 PBT0.181.26 -86 NP0.170.94 -82 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to hold board meeting

Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit declines 41.67% in the March 2025 quarter

Net profit of Arvee Laboratories (India) declined 41.67% to Rs 0.07 crore in the quarter ended March 2025 as against Rs 0.12 crore during the previous quarter ended March 2024. Sales rose 5.05% to Rs 6.45 crore in the quarter ended March 2025 as against Rs 6.14 crore during the previous quarter ended March 2024. For the full year,net profit rose 104.76% to Rs 2.15 crore in the year ended March 2025 as against Rs 1.05 crore during the previous year ended March 2024. Sales rose 26.82% to Rs 38.49 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales6.456.14 5 38.4930.35 27 OPM %3.4113.03 -9.389.88 - PBDT0.360.96 -63 4.023.33 21 PBT0.090.59 -85 2.871.83 57 NP0.070.12 -42 2.151.05 105 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to hold board meeting

Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 9 May 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit declines 37.50% in the December 2024 quarter

Net profit of Arvee Laboratories (India) declined 37.50% to Rs 0.15 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 15.71% to Rs 8.91 crore in the quarter ended December 2024 as against Rs 7.70 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales8.917.70 16 OPM %3.826.88 - PBDT0.480.67 -28 PBT0.200.32 -38 NP0.150.24 -38 Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Arvee Laboratories (India) Ltd (ARVEE) today?

    The share price of ARVEE as on 2nd March 2026 is ₹154. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Arvee Laboratories (India) Ltd (ARVEE) share?

    The past returns of Arvee Laboratories (India) Ltd (ARVEE) share are
    • Past 1 week: -7.78%
    • Past 1 month: -3.75%
    • Past 3 months: -6.58%
    • Past 6 months: -5.63%
    • Past 1 year: 12.75%
    • Past 3 years: 46.60%
    • Past 5 years: 253.62%

  3. What are the peers or stocks similar to Arvee Laboratories (India) Ltd (ARVEE)?
  4. What is the market cap of Arvee Laboratories (India) Ltd (ARVEE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Arvee Laboratories (India) Ltd (ARVEE) is ₹169.71 Cr as of 2nd March 2026.

  5. What is the 52 week high and low of Arvee Laboratories (India) Ltd (ARVEE) share?

    The 52-week high of Arvee Laboratories (India) Ltd (ARVEE) is ₹290.78 and the 52-week low is ₹134.33.

  6. What is the PE and PB ratio of Arvee Laboratories (India) Ltd (ARVEE) stock?

    The P/E (price-to-earnings) ratio of Arvee Laboratories (India) Ltd (ARVEE) is 79.30. The P/B (price-to-book) ratio is 5.83.

  7. Which sector does Arvee Laboratories (India) Ltd (ARVEE) belong to?

    Arvee Laboratories (India) Ltd (ARVEE) belongs to the Materials sector & Specialty Chemicals sub-sector.

  8. How to buy Arvee Laboratories (India) Ltd (ARVEE) shares?

    You can directly buy Arvee Laboratories (India) Ltd (ARVEE) shares on Tickertape. Simply sign up, connect your demat account and place your order.